Absorption and activity of 2,6-bis-(diethanolamino)-4,8-dipiperidino-pyrimido-(5,4-d) pyrimidine (RA8) following enteric administration.
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D003331:Coronary Vessels / Q000187:drug effects*; D004176:Dipyridamole / Q000097:blood / Q000378:metabolism*; D004285:Dogs; D004386:Duodenum; D007408:Intestinal Absorption; D012039:Regional Blood Flow
D004176:Dipyridamole